Literature DB >> 24678775

The role of tyrosine kinases in systemic lupus erythematosus and their potential as therapeutic targets.

Wen-Hai Shao1, Philip L Cohen.   

Abstract

The autoimmune disease systemic lupus erythematosus is characterized by loss of tolerance to nuclear antigens. Breakdown of tolerance is associated with alterations in T-cell and B-cell receptor signal transduction, including increased protein phosphorylation that may underlie pathogenesis and explain the characteristic hyperactivity of T and B cells and other immune cells in active disease. Tyrosine kinases play a central role in signaling processes in cells known to be important in the pathogenesis of autoimmune diseases. Considerable progress has been made in understanding the function of tyrosine kinases in immune cell signaling pathways. In this review, we will summarize the function of tyrosine kinases and their novel inhibitors from studies made in animal lupus models and systemic lupus erythematosus patients.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24678775      PMCID: PMC4249585          DOI: 10.1586/1744666X.2014.893827

Source DB:  PubMed          Journal:  Expert Rev Clin Immunol        ISSN: 1744-666X            Impact factor:   4.473


  82 in total

1.  TAM receptors are pleiotropic inhibitors of the innate immune response.

Authors:  Carla V Rothlin; Sourav Ghosh; Elina I Zuniga; Michael B A Oldstone; Greg Lemke
Journal:  Cell       Date:  2007-12-14       Impact factor: 41.582

Review 2.  Immunobiology of the TAM receptors.

Authors:  Greg Lemke; Carla V Rothlin
Journal:  Nat Rev Immunol       Date:  2008-05       Impact factor: 53.106

3.  Association of polymorphisms across the tyrosine kinase gene, TYK2 in UK SLE families.

Authors:  D S Cunninghame Graham; M Akil; T J Vyse
Journal:  Rheumatology (Oxford)       Date:  2007-03-23       Impact factor: 7.580

Review 4.  T-cell receptor proximal signaling via the Src-family kinases, Lck and Fyn, influences T-cell activation, differentiation, and tolerance.

Authors:  Robert J Salmond; Andrew Filby; Ihjaaz Qureshi; Stefano Caserta; Rose Zamoyska
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

Review 5.  Is there a future for small molecule drugs in the treatment of rheumatic diseases?

Authors:  Joanna Stanczyk; Caroline Ospelt; Steffen Gay
Journal:  Curr Opin Rheumatol       Date:  2008-05       Impact factor: 5.006

6.  Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX.

Authors:  Geoffrey Hom; Robert R Graham; Barmak Modrek; Kimberly E Taylor; Ward Ortmann; Sophie Garnier; Annette T Lee; Sharon A Chung; Ricardo C Ferreira; P V Krishna Pant; Dennis G Ballinger; Roman Kosoy; F Yesim Demirci; M Ilyas Kamboh; Amy H Kao; Chao Tian; Iva Gunnarsson; Anders A Bengtsson; Solbritt Rantapää-Dahlqvist; Michelle Petri; Susan Manzi; Michael F Seldin; Lars Rönnblom; Ann-Christine Syvänen; Lindsey A Criswell; Peter K Gregersen; Timothy W Behrens
Journal:  N Engl J Med       Date:  2008-01-20       Impact factor: 91.245

7.  Expression of a chimeric CSF1R-LTK mediates ligand-dependent neurite outgrowth.

Authors:  Shigeru Yamada; Takashi Nomura; Kota Takano; Satoshi Fujita; Masato Miyake; Jun Miyake
Journal:  Neuroreport       Date:  2008-11-19       Impact factor: 1.837

8.  Btk regulates localization, in vivo activation, and class switching of anti-DNA B cells.

Authors:  Kristina E Halcomb; Sandirai Musuka; Toni Gutierrez; Heather L Wright; Anne B Satterthwaite
Journal:  Mol Immunol       Date:  2008-10-11       Impact factor: 4.407

9.  An orally bioavailable spleen tyrosine kinase inhibitor delays disease progression and prolongs survival in murine lupus.

Authors:  Frances Rena Bahjat; Polly R Pine; Andrea Reitsma; Gail Cassafer; Muhammad Baluom; Sunny Grillo; Betty Chang; Fei Fei Zhao; Donald G Payan; Elliott B Grossbard; David I Daikh
Journal:  Arthritis Rheum       Date:  2008-05

10.  Differential expression and molecular associations of Syk in systemic lupus erythematosus T cells.

Authors:  Sandeep Krishnan; Yuang-Taung Juang; Bhabadeb Chowdhury; Abigail Magilavy; Carolyn U Fisher; Hang Nguyen; Madhusoodana P Nambiar; Vasileios Kyttaris; Arthur Weinstein; Rena Bahjat; Polly Pine; Violeta Rus; George C Tsokos
Journal:  J Immunol       Date:  2008-12-01       Impact factor: 5.422

View more
  12 in total

Review 1.  Genetics and pathogenesis of systemic lupus erythematosus and lupus nephritis.

Authors:  Chandra Mohan; Chaim Putterman
Journal:  Nat Rev Nephrol       Date:  2015-03-31       Impact factor: 28.314

2.  PKK deficiency in B cells prevents lupus development in Sle lupus mice.

Authors:  D Oleksyn; J Zhao; A Vosoughi; J C Zhao; R Misra; A P Pentland; D Ryan; J Anolik; C Ritchlin; J Looney; A P Anandarajah; G Schwartz; L M Calvi; M Georger; C Mohan; I Sanz; L Chen
Journal:  Immunol Lett       Date:  2017-03-06       Impact factor: 3.685

Review 3.  Src Family Protein Kinase Controls the Fate of B Cells in Autoimmune Diseases.

Authors:  Xianzheng Zhang; Dan Mei; Lingling Zhang; Wei Wei
Journal:  Inflammation       Date:  2020-10-10       Impact factor: 4.092

Review 4.  Non-receptor tyrosine kinase signaling in autoimmunity and therapeutic implications.

Authors:  Sabrina Solouki; Avery August; Weishan Huang
Journal:  Pharmacol Ther       Date:  2019-05-11       Impact factor: 12.310

Review 5.  Treat-to-target in systemic lupus erythematosus: advancing towards its implementation.

Authors:  Agner R Parra Sánchez; Alexandre E Voskuyl; Ronald F van Vollenhoven
Journal:  Nat Rev Rheumatol       Date:  2022-01-17       Impact factor: 20.543

Review 6.  Possible evidence of systemic lupus erythematosus and periodontal disease association mediated by Toll-like receptors 2 and 4.

Authors:  C P C Marques; Y Maor; M S de Andrade; V P Rodrigues; B B Benatti
Journal:  Clin Exp Immunol       Date:  2015-11-05       Impact factor: 4.330

7.  Lyn kinase enhanced hepatic fibrosis by modulating the activation of hepatic stellate cells.

Authors:  Yin Li; Lin Xiong; Jianping Gong
Journal:  Am J Transl Res       Date:  2017-06-15       Impact factor: 4.060

8.  HM71224, a selective Bruton's tyrosine kinase inhibitor, attenuates the development of murine lupus.

Authors:  Yu-Yon Kim; Ki Tae Park; Sun Young Jang; Kyu Hang Lee; Joo-Yun Byun; Kwee Hyun Suh; Young-Mi Lee; Young Hoon Kim; Kwang Woo Hwang
Journal:  Arthritis Res Ther       Date:  2017-09-26       Impact factor: 5.156

Review 9.  Tyrosine kinase inhibitors and mesenchymal stromal cells: effects on self-renewal, commitment and functions.

Authors:  Adriana Borriello; Ilaria Caldarelli; Debora Bencivenga; Emanuela Stampone; Silverio Perrotta; Adriana Oliva; Fulvio Della Ragione
Journal:  Oncotarget       Date:  2017-01-17

Review 10.  Lyn, Lupus, and (B) Lymphocytes, a Lesson on the Critical Balance of Kinase Signaling in Immunity.

Authors:  Erica J Brodie; Simona Infantino; Michael S Y Low; David M Tarlinton
Journal:  Front Immunol       Date:  2018-03-01       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.